Results 271 to 280 of about 58,205 (308)

Differences in Executive Functioning Between Patients with IDH1-Mutant Oligodendroglioma and Astrocytoma Before and After Surgery. [PDF]

Cancers (Basel)
Landers-Wouters M, Brouwers B, Rutten GJ, Butterbrod E.   +3 more
europepmc   +1 more source

MiR-205-5p downregulation and circ_100290 upregulation in glioblastoma patients are associated with tumor aggressiveness. [PDF]

Discov Oncol
Eghtedari S, Arbabian S, Rezagholizadeh F, Talebi M, Bahrami R, Entezari M, Joghataei MT.   +6 more
europepmc   +1 more source

The power and the promise of epigenetic drugs in oncology. [PDF]

Front Genet
Scandolara TB, Siqueira IVM, Ribeiro Pinto LF, Soares-Lima SC.   +3 more
europepmc   +1 more source

IDH1 NM_005896.3:c.395_396delGTinsAC [PDF]

, 2020
openaire   +1 more source

Amino acid metabolic reprogramming: future prospects for cholangiocarcinoma therapy. [PDF]

Cell Death Discov
Hua S, Fei F, Li J, Liu Y, Gao Y, Wang X, Dong X, Liu Q, Yang J.   +8 more
europepmc   +1 more source

Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in reduced glioma cell viability in vitro [PDF]

, 2015
Ashkan, Keyoumars, Butt, Arthur M., Fillmore, Helen L., Higgins, Samantha C., Pilkington, Geoffrey J.   +4 more
core   +1 more source

Supplementary Table S2 from FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an <i>IDH1</i> Mutation

Ashley Woods, Kelly J. Norsworthy, Xin Wang, Jonathon Vallejo, Edwin C.Y. Chow, Ruo‐Jing Li, Jielin Sun, Rosane Charlab, Xiling Jiang, Richard Pazdur, Marc R. Theoret, R. Angelo de Claro   +11 more
openalex   +1 more source

Comprehensive analysis of cuproptosis-related genes in diabetic cardiomyopathy. [PDF]

PLoS One
Li J, Zhang H, Duan X, Zhang M, Li X, Hao C.   +5 more
europepmc   +1 more source

Zdravljenje IDH1 astrocitoma

Tomič, Blaž, Mesti, Tanja
openaire   +1 more source

Melanoma of unknown primary: a comprehensive review of immune-mediated pathogenesis and therapies. [PDF]

Oncologist
Xu W, Gui J, Guo P, Zhang Y, Wu D.
europepmc   +1 more source